BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2481741)

  • 1. A randomized trial of cyclobenzaprine for the treatment of fibromyalgia.
    Quimby LG; Gratwick GM; Whitney CD; Block SR
    J Rheumatol Suppl; 1989 Nov; 19():140-3. PubMed ID: 2481741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis.
    Tofferi JK; Jackson JL; O'Malley PG
    Arthritis Rheum; 2004 Feb; 51(1):9-13. PubMed ID: 14872449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the role of tricyclic medications in the treatment of fibromyalgia syndrome.
    Goldenberg DL
    J Rheumatol Suppl; 1989 Nov; 19():137-9. PubMed ID: 2691673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bedtime very low dose cyclobenzaprine on symptoms and sleep physiology in patients with fibromyalgia syndrome: a double-blind randomized placebo-controlled study.
    Moldofsky H; Harris HW; Archambault WT; Kwong T; Lederman S
    J Rheumatol; 2011 Dec; 38(12):2653-63. PubMed ID: 21885490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia.
    Reynolds WJ; Moldofsky H; Saskin P; Lue FA
    J Rheumatol; 1991 Mar; 18(3):452-4. PubMed ID: 1856814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial.
    Carette S; Bell MJ; Reynolds WJ; Haraoui B; McCain GA; Bykerk VP; Edworthy SM; Baron M; Koehler BE; Fam AG
    Arthritis Rheum; 1994 Jan; 37(1):32-40. PubMed ID: 8129762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The plasma endorphin, prostaglandin and catecholamine profile of patients with fibrositis treated with cyclobenzaprine and placebo: a 5-month study.
    Hamaty D; Valentine JL; Howard R; Howard CW; Wakefield V; Patten MS
    J Rheumatol Suppl; 1989 Nov; 19():164-8. PubMed ID: 2532682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fluoxetin combined with cyclobenzaprine in the treatment of fibromyalgia].
    Cantini F; Bellandi F; Niccoli L; Di Munno O
    Minerva Med; 1994 Mar; 85(3):97-100. PubMed ID: 8196850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of fibromyalgia syndrome.
    Goldenberg DL
    Rheum Dis Clin North Am; 1989 Feb; 15(1):61-71. PubMed ID: 2644679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial.
    Gür A; Karakoc M; Nas K; Cevik R; Sarac J; Ataoglu S
    Rheumatol Int; 2002 Sep; 22(5):188-93. PubMed ID: 12215864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons learned combining N-of-1 trials to assess fibromyalgia therapies.
    Zucker DR; Ruthazer R; Schmid CH; Feuer JM; Fischer PA; Kieval RI; Mogavero N; Rapoport RJ; Selker HP; Stotsky SA; Winston E; Goldenberg DL
    J Rheumatol; 2006 Oct; 33(10):2069-77. PubMed ID: 17014022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined therapy with cyclobenzaprine and ibuprofen in primary fibromyalgia syndrome.
    Fossaluzza V; De Vita S
    Int J Clin Pharmacol Res; 1992; 12(2):99-102. PubMed ID: 1428304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
    Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A
    J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
    Holman AJ; Myers RR
    Arthritis Rheum; 2005 Aug; 52(8):2495-505. PubMed ID: 16052595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
    Arnold LM; Hudson JI; Wang F; Wohlreich MM; Prakash A; Kajdasz DK; Chappell AS
    Clin J Pain; 2009; 25(6):461-8. PubMed ID: 19542792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclobenzaprine with ibuprofen versus ibuprofen alone in acute myofascial strain: a randomized, double-blind clinical trial.
    Turturro MA; Frater CR; D'Amico FJ
    Ann Emerg Med; 2003 Jun; 41(6):818-26. PubMed ID: 12764337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
    Bremner JD
    J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antidepressant mirtazapine on fibromyalgia symptoms.
    Samborski W; Lezańska-Szpera M; Rybakowski JK
    Rocz Akad Med Bialymst; 2004; 49():265-9. PubMed ID: 15631355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of preliminary criteria for response to treatment in fibromyalgia syndrome.
    Simms RW; Felson DT; Goldenberg DL
    J Rheumatol; 1991 Oct; 18(10):1558-63. PubMed ID: 1765981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.